Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eman G. Ayad"'
Autor:
Amira A. Goda, Eman G. Ayad, Menna H. Amin, Mahmoud Youssef, Jianrong Shi, Jianhong Xu, Xin Liu, You Zhou, Liwen Xiao, Sherif Ramzy
Publikováno v:
Discover Food, Vol 4, Iss 1, Pp 1-13 (2024)
Abstract Due to the potential health risks of synthetic food preservatives, there has been a noticeable increase in interest in finding natural food preservatives during the past few decades. The goal of this study was to investigate the use of a nat
Externí odkaz:
https://doaj.org/article/41846b10500c4d0ca095b4b480c51368
Autor:
Doaa Abou El-ezz, Laila H. Abdel-Rahman, Badriah Saad Al-Farhan, Dalia A. Mostafa, Eman G. Ayad, Maram T. Basha, Mahmoud Abdelaziz, Ehab M. Abdalla
Publikováno v:
Pharmaceuticals, Vol 15, Iss 8, p 978 (2022)
Wound dressings created using nanotechnology are known as suitable substrates to speed up the healing of both acute and chronic wounds. Therapeutic substances can be delivered using these materials. In this study, a hydrogel loaded with Cu (II) Schif
Externí odkaz:
https://doaj.org/article/ffed3446f6c0421ca622831cf8d1bbbe
Autor:
Hayat M. Sharada, Eman G. Ayad, Mohga S. Abdulla, Abeer M. Ashmawy, Abdel Hady A. Abdel Wahab
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 22:2951-2958
Objective The purpose of the current study was to investigate the possible anti-tumor effect of miR-27a inhibitor in combination with Sorafenib (SOR) on cell proliferation and apoptosis of hepatocellular carcinoma cell lines. Methods Transient transf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372e4ce1ca411b57539ec8bd56232403
https://doi.org/10.31557/apjcp.2021.22.9.2951
https://doi.org/10.31557/apjcp.2021.22.9.2951
Autor:
Hayat M. Sharada, Mohga S. Abdulla, Eman G. Ayad, Abeer M. Ashmawy, Abdel Hady A. Abdel Wahab
Publikováno v:
Journal of Bioscience and Applied Research. 5:340-351
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through post-transcriptional interactions with mRNA. MiRNAs have recently been considered as key regulators of various cancers including liver cancer. Sorafenib is one of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc3b82e1f0a9eb36166e789ce458ed29
https://doi.org/10.21608/jbaar.2019.147398
https://doi.org/10.21608/jbaar.2019.147398